![]() |
Name |
Melicopicine
|
Molecular Formula | C18H19NO5 | |
IUPAC Name* |
1,2,3,4-tetramethoxy-10-methylacridin-9-one
|
|
SMILES |
CN1C2=CC=CC=C2C(=O)C3=C1C(=C(C(=C3OC)OC)OC)OC
|
|
InChI |
InChI=1S/C18H19NO5/c1-19-11-9-7-6-8-10(11)14(20)12-13(19)16(22-3)18(24-5)17(23-4)15(12)21-2/h6-9H,1-5H3
|
|
InChIKey |
URPVDDXMEZAEJY-UHFFFAOYSA-N
|
|
Synonyms |
Melicopicine; 517-73-7; 9(10H)-Acridinone, 1,2,3,4-tetramethoxy-10-methyl-; Melicopicene; 1,2,3,4-Tetramethoxy-10-methylacridin-9(10H)-one; 1,2,3,4-tetramethoxy-10-methylacridin-9-one; 9-Acridanone, 1,2,3,4-tetramethoxy-10-methyl-; CHEBI:6734; NSC-402921; 1,2,3,4-Tetramethoxy-10-methyl-9(10H)-acridinone; AC1L2QFT; EINECS 208-244-1; 4UCL445ULN; CHEMBL455628; MEGxp0_000254; DTXSID2075429; SCHEMBL15941244; NSC402921; NSC 402921; NCI60_003789; 9-Acridanone,2,3,4-tetramethoxy-10-methyl-; 9(10H)-Acridinone,2,3,4-tetramethoxy-10-methyl-; Q27107315; 1,2,3,4-Tetramethoxy-10-methyl-9(10H)-acridinone #; Acridin-9(10H)-one, 10-methyl-1,2,3,4-tetramethoxy-
|
|
CAS | 517-73-7 | |
PubChem CID | 101253 | |
ChEMBL ID | CHEMBL455628 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 329.3 | ALogp: | 3.0 |
HBD: | 0 | HBA: | 6 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 57.2 | Aromatic Rings: | 3 |
Heavy Atoms: | 24 | QED Weighted: | 0.686 |
Caco-2 Permeability: | -4.674 | MDCK Permeability: | 0.00003970 |
Pgp-inhibitor: | 0.142 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.036 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.004 |
Blood-Brain-Barrier Penetration (BBB): | 0.651 | Plasma Protein Binding (PPB): | 87.24% |
Volume Distribution (VD): | 0.716 | Fu: | 12.68% |
CYP1A2-inhibitor: | 0.73 | CYP1A2-substrate: | 0.984 |
CYP2C19-inhibitor: | 0.831 | CYP2C19-substrate: | 0.922 |
CYP2C9-inhibitor: | 0.646 | CYP2C9-substrate: | 0.896 |
CYP2D6-inhibitor: | 0.029 | CYP2D6-substrate: | 0.869 |
CYP3A4-inhibitor: | 0.584 | CYP3A4-substrate: | 0.86 |
Clearance (CL): | 1.991 | Half-life (T1/2): | 0.281 |
hERG Blockers: | 0.202 | Human Hepatotoxicity (H-HT): | 0.058 |
Drug-inuced Liver Injury (DILI): | 0.077 | AMES Toxicity: | 0.572 |
Rat Oral Acute Toxicity: | 0.463 | Maximum Recommended Daily Dose: | 0.071 |
Skin Sensitization: | 0.182 | Carcinogencity: | 0.689 |
Eye Corrosion: | 0.009 | Eye Irritation: | 0.853 |
Respiratory Toxicity: | 0.399 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000701 | ![]() |
0.460 | D02LZB | ![]() |
0.369 | ||
ENC005522 | ![]() |
0.406 | D09DHY | ![]() |
0.352 | ||
ENC001405 | ![]() |
0.374 | D0G4KG | ![]() |
0.322 | ||
ENC002158 | ![]() |
0.361 | D06GCK | ![]() |
0.311 | ||
ENC001571 | ![]() |
0.356 | D01FFA | ![]() |
0.308 | ||
ENC002566 | ![]() |
0.344 | D04TDQ | ![]() |
0.302 | ||
ENC004691 | ![]() |
0.344 | D0NJ3V | ![]() |
0.292 | ||
ENC004688 | ![]() |
0.344 | D06GKN | ![]() |
0.290 | ||
ENC001403 | ![]() |
0.336 | D0Y7TS | ![]() |
0.282 | ||
ENC005037 | ![]() |
0.330 | D0K7WK | ![]() |
0.277 |